TIS Capital, part of Unify Investment Group, backs Taiwan and Asia-Pacific companies with financial strategy, cross-border M&A, and early-stage incubation across deep-tech and biomedical — plus an IP program that raises value at exit.
Rooted in Taiwan and Asia-Pacific, we work alongside companies on three fronts — and back each with an IP program that makes what you build worth more, and safer.
Financial-strategy advisory tailored to Taiwanese enterprises.
Cross-border M&A consulting that bridges Asia-Pacific and global markets.
Early-stage investment matching and incubation across deep-tech and biomedical ecosystems.
Most investors underwrite the technology and hope the IP holds up. We do it in the opposite order — we clear the infringement risk before we invest, then build a patent wall after. Capital and protection move together, so your growth becomes lasting, defensible value instead of a bigger target.
We aim the Capital × IP dual engine at one thing: the structural growth of Taiwan's defense and dual-use unmanned vehicles — a sector scaling at once-in-a-cycle speed, before its patent walls are built.
Taiwan's UAV sector is scaling at once-in-a-cycle speed.
The field's IP is wide open — for now.
Wait, and you scale straight into someone else's patents.
IP first, then capital behind it — the opposite of how most investors work.
Before we invest
An AI-driven audit against a top-tier global patent database maps your infringement exposure and the field's open white-space. You scale knowing where the risks are — not discovering them in a lawsuit.
After we invest
TIS files high-quality patents around your technology and connects you to a shared defense pool. Because we're the investor, the program actually gets built — not just recommended.
Any firm can write a patent. What compounds your value is the engine behind it and the position it's filed from.
Audits run on Innovue — a top-tier global patent database — so risk and white-space are measured, not guessed.
Portfolio companies license patents into a common pool that licenses back out to everyone in it. The earlier you join, the deeper the pool you share in.
International capital + Taiwan non-red manufacturing + clean IP — a hard selling point to global buyers. Our stance is reverse-NPE: IP protects your value, it doesn't start lawsuits.
A growing portfolio of our own patents forms an invisible moat around the companies we back — protection that travels with the fund, not any single deal.
Filed and acquired across the domains our rating engine flags as undervalued and genuinely defensible.
Owned protection spans the whole portfolio — value that travels with the fund, not a single deal.
TIS-owned patents help seed the Cross-License Commons every backed company can draw on.
Technology with a moat commands higher multiples and exit premiums.
Pre-investment FTO clearance heads off infringement suits and injunctions abroad.
A clean, defensible portfolio is one of the assets reviewers and international buyers value most.
The shared pool means you don't face a foreign NPE by yourself.
A long-term partner that grows with you — not a one-time transaction.